对于内科医生而言,心肌桥梁的当代审查
Muhammad Ajmal1, Bilaval Javed2, Saad Kubba1
1University of Arizona, Sarver Heart Center, College of Medicine, Tucson; Banner University Medicine, Tucson, Ariz.
The American journal of medicine
|March 5, 2025
概括
心肌桥架,一种先天性心脏病,动脉在心肌内运行,可以引起心痛,增加心血管风险. 本综述澄清了其诊断,机制和管理,以更好地了解临床.
科学领域:
- 心脏病学 心脏病学
- 遗传性心脏病是一种先天性心脏病.
- 血管生物学 血管生物学
背景情况:
- 心肌桥架是一种先天性冠状动脉异常,其中心脏上动脉在心肌内穿过道.
- 患病率因诊断方法而异,从血管学中的0.5%到尸检研究中的80%.
- 历史上被认为是良性的,最近的证据将其与心痛和不良心血管事件联系起来.
研究的目的:
- 审查心肌桥架的临床表现和诊断方式.
- 阐明心肌桥架中心痛背后的病理生理机制.
- 提出基于患者表型的评估和治疗算法.
主要方法:
- 关于心肌架桥研究的文献综述.
- 对诊断成像技术 (解剖,CT血管学,侵入性血管学) 的分析.
- 综合了关于症状,风险因素和结果的临床数据.
主要成果:
- 心肌桥架可以表现为慢性心痛,即使在非阻塞性冠状动脉疾病.
- 与重大心血管不良事件的风险增加有关.
- 临床医生对诊断不足和评估不足有助于低于最佳的管理.
结论:
- 心肌桥架是心肌痛和心血管事件的一个未被认可的原因.
- 准确的诊断和对其机制的理解至关重要.
- 建议采用表型导向的治疗方法来有效管理.
相关概念视频
Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...


